
Sign up to save your podcasts
Or


In the second part of this two-part series, Dr. Kaitlyn Palmer explains how these biomarkers change our approach to diagnosing multiple sclerosis.
Show reference:
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Montalban, Xavier, et al. The Lancet Neurology, Volume 24, Issue 10, 850 - 865
By American Academy of Neurology4.8
132132 ratings
In the second part of this two-part series, Dr. Kaitlyn Palmer explains how these biomarkers change our approach to diagnosing multiple sclerosis.
Show reference:
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Montalban, Xavier, et al. The Lancet Neurology, Volume 24, Issue 10, 850 - 865

328 Listeners

500 Listeners

303 Listeners

54 Listeners

297 Listeners

3,380 Listeners

13 Listeners

1,154 Listeners

27 Listeners

197 Listeners

90 Listeners

517 Listeners

362 Listeners

187 Listeners

82 Listeners